Clear Acne Face Moisturizer Lotion
NDC Package 50718-0033-1
Package Information
Clear Acne Face Moisturizer (acne face moisturizer) lotions is cleanse the skin thoroughly before applying medication.Cover the entire affected area with a thin layer one to three times daily.Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.If bothersome dryness or peeling occurs, reduce application to once a day or every other day.For children under 10 years of age, consult your physician. This formulation utilizes a lotion delivery system. Marketed by Kamedis, this product is identified by NDC 50718-0033 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 103568 - salicylic acid 2 % Topical Lotion
- RxCUI: 103568 - salicylic acid 20 MG/ML Topical Lotion
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 50718 - Kamedis
- 50718-0033 - Clear Acne Face Moisturizer
- 50718-0033-1 - 1 BOTTLE in 1 CARTON / 50 mL in 1 BOTTLE
- 50718-0033 - Clear Acne Face Moisturizer
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50718-0033-1 identifies a specific commercial package of 1 bottle in 1 carton / 50 ml in 1 bottle of Clear Acne Face Moisturizer, a human over the counter drug labeled by Kamedis. This lotion is formulated for topical use and contains salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Kamedis on January 01, 2018. The current certification is valid through December 31, 2026.
How is this Kamedis product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50718003301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.